Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations

Melinta Therapeutics Inc. (MLNT)

1.4   0.04 (2.94%) 11-14 16:00
Open: 1.28 Pre. Close: 1.36
High: 1.4137 Low: 1.25
Volume: 576,705 Market Cap: 20M
Melinta Therapeutics Inc is a commercial-stage biopharmaceutical company. It is developing antibiotic, Baxdela (delafloxacin), for the treatment of adults with serious skin infections known as acute bacterial skin and skin structure infections.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 1.411 - 1.421 1.421 - 1.429
Low: 1.233 - 1.243 1.243 - 1.25
Close: 1.386 - 1.403 1.403 - 1.415

Technical analysis

as of: 2019-11-14 4:31:13 PM
Stoxline posted a NEUTRAL today, upgraded from lower rating. Current trend continues, but could change at anytime. It is not a good time to buy or sell.
Target: Six months: 4.52     One year: 6.56
Support: Support1: 1.03    Support2: 0.86
Resistance: Resistance1: 3.87    Resistance2: 5.62
Pivot: 2.49
Moving Average: MA(5): 1.79     MA(20): 3.01
MA(100): 3.58     MA(250): 4.61
MACD: MACD(12,26): -0.53     Signal(9): -0.34
Stochastic oscillator: %K(14,3): 8.25     %D(3): 5.29
RSI: RSI(14): 24.86
52-week: High: 14.25  Low: 1.03  Change(%): -89.9
Average Vol(K): 3-Month: 49611  10-Days: 64965

Price, moving averages and Bollinger Bands

Price and moving averages has closed below its Short term moving average. Short term moving average is currently below mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BEARISH in short-term; and BEARISH in mid-long term.
MLNT has closed above bottom band by 3.1%. Bollinger Bands are 8.4% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Headline News

Sat, 28 Sep 2019 01:34:53 +0000
Biotech Stocks Facing FDA Decision In October 2019

Tue, 24 Sep 2019 02:52:28 +0000
6 Top Gainers In Healthcare Sector (AVDL, KOOL, MLNT…)

Wed, 11 Sep 2019 02:44:14 +0000
5 Top Gainers In Healthcare Sector (MNK, ENDP, MLNT...)

Tue, 16 Jul 2019 13:21:36 +0000
Health Care Sector Update for 07/16/2019: IMRN, MLNT, JNJ, PFE, ABT, MRK, AMGN

Wed, 19 Jun 2019 14:27:30 +0000
Mid-Morning Market Update: Markets Mixed; Winnebago Industries Reports Mixed Q3 Results

Financial Analysis

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Click here to get more fundamental analysis.
Tweet this page Share on Facebook
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  Nasdaq Global Select
Sector:  Healthcare
Industry:  Biotechnology
Shares Out. (M) 13.75
Shares Float (M) 10.29
% Held by Insiders 7.28
% Held by Institutions 62.46
Shares Short (K) 1430
Shares Short P. Month (K)

Stock Financials

EPS -11.813
Book Value (p.s.) 11.980
PEG Ratio
Profit Margin -135.23
Operating Margin -90.68
Return on Assets (ttm) -11.8
Return on Equity (ttm) -66.9
Qtrly Rev. Growth 32.7
Gross Profit (p.s.) 0.069
Sales Per Share
EBITDA (p.s.) -5.345
Qtrly Earnings Growth
Operating Cash Flow (M) -128.79
Levered Free Cash Flow (M) -45.78

Stock Valuations

P/E -0.12
P/E Growth Ratio 0.03
P/BV 0.12
P/S 0.16
P/CF -0.15

Dividends & Splits

Dividend Yield
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
Forward Dividend
Last Split Date 2019-02-22
Last Split Ratio -1e+010
7 Binary Options
Your Ad Here
Stock Chart
Stoxline Lite
Stoxline Pro
Option Calculator
(c) 2006-2019 | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the web site, a user agrees not to redistribute the information found therein.